These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8006405)

  • 1. Is ursodeoxycholic acid an effective therapy for total parenteral nutrition-related liver disease?
    Beau P; Labat-Labourdette J; Ingrand P; Beauchant M
    J Hepatol; 1994 Feb; 20(2):240-4. PubMed ID: 8006405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biochemical and histopathological effects of ursodeoxycholic acid and metronidazole on total parenteral nutrition-associated hepatic dysfunction: an experimental study.
    Günsar C; Melek M; Karaca I; Sencan A; Mir E; Ortaç R; Canan O
    Hepatogastroenterology; 2002; 49(44):497-500. PubMed ID: 11995481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parenteral nutrition-associated cholestasis in preterm neonates: evaluation of ursodeoxycholic acid treatment.
    Levine A; Maayan A; Shamir R; Dinari G; Sulkes J; Sirotta L
    J Pediatr Endocrinol Metab; 1999; 12(4):549-53. PubMed ID: 10417972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursodeoxycholic acid therapy for intractable total parenteral nutrition-associated cholestasis in surgical very low birth weight infants.
    Al-Hathlol K; Al-Madani A; Al-Saif S; Abulaimoun B; Al-Tawil K; El-Demerdash A
    Singapore Med J; 2006 Feb; 47(2):147-51. PubMed ID: 16435058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study.
    Spagnuolo MI; Iorio R; Vegnente A; Guarino A
    Gastroenterology; 1996 Sep; 111(3):716-9. PubMed ID: 8780577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ursodeoxycholic acid therapy in children with cholestatic liver disease.
    Dinler G; Koçak N; Yüce A; Gürakan F; Ozen H
    Turk J Pediatr; 1999; 41(1):91-8. PubMed ID: 10770681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Total parenteral nutrition-related cholestatic hepatopathy, is it an infectious disease?].
    Beau P; Barrioz T; Ingrand P
    Gastroenterol Clin Biol; 1994; 18(1):63-7. PubMed ID: 8187992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ursodeoxycholic acid for the treatment of home parenteral nutrition-associated cholestasis. A case report.
    Lindor KD; Burnes J
    Gastroenterology; 1991 Jul; 101(1):250-3. PubMed ID: 1904380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early treatment with ursodeoxycholic acid for cholestasis in children on parenteral nutrition because of primary intestinal failure.
    De Marco G; Sordino D; Bruzzese E; Di Caro S; Mambretti D; Tramontano A; Colombo C; Simoni P; Guarino A
    Aliment Pharmacol Ther; 2006 Jul; 24(2):387-94. PubMed ID: 16842466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholic acid therapy in hepatobiliary disease.
    Kowdley KV
    Am J Med; 2000 Apr; 108(6):481-6. PubMed ID: 10781781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity and specificity of liver function tests in the detection of parenteral nutrition-associated cholestasis.
    Nanji AA; Anderson FH
    JPEN J Parenter Enteral Nutr; 1985; 9(3):307-8. PubMed ID: 2861299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extreme short bowel syndrome in a full-term neonate--a case report.
    Heemskerk J; Sie GH; Van den Neucker AM; Forget PP; Heineman E; van Heurn LW
    J Pediatr Surg; 2003 Nov; 38(11):1665-6. PubMed ID: 14614721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of parenteral nutrition-associated cholestasis with cholecystokinin-octapeptide.
    Teitelbaum DH; Han-Markey T; Schumacher RE
    J Pediatr Surg; 1995 Jul; 30(7):1082-5. PubMed ID: 7472937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ursodeoxycholic acid for treatment of cholestasis in patients with hepatic amyloidosis.
    Faust D; Akoglu B; Ristic G; Milovic V
    Vojnosanit Pregl; 2009 Jun; 66(6):482-6. PubMed ID: 19583148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease.
    Gura KM; Lee S; Valim C; Zhou J; Kim S; Modi BP; Arsenault DA; Strijbosch RA; Lopes S; Duggan C; Puder M
    Pediatrics; 2008 Mar; 121(3):e678-86. PubMed ID: 18310188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal liver functions as a result of total parenteral nutrition in a patient with short-bowel syndrome.
    Burstyne M; Jensen GL
    Nutrition; 2000; 16(11-12):1090-2. PubMed ID: 11118832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment.
    Ersöz G; Günşar F; Karasu Z; Akay S; Batur Y; Akarca US
    Turk J Gastroenterol; 2005 Sep; 16(3):124-8. PubMed ID: 16245220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodeoxycholic acid prevents hepatic cytochrome P450 isozyme reduction in rats with deoxycholic acid-induced liver injury.
    Tanaka M; Nakura H; Tateishi T; Watanabe M; Nakaya S; Kumai T; Kobayashi S
    J Hepatol; 1999 Aug; 31(2):263-70. PubMed ID: 10453939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cholestasis associated with prolonged parenteral nutrition in neonates: the role of urso-deoxycholic acid].
    Garzón L; Ledo A; Cubells E; Sáenz P; Vento M
    An Pediatr (Barc); 2009 Jun; 70(6):547-52. PubMed ID: 19443280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis.
    Cotting J; Lentze MJ; Reichen J
    Gut; 1990 Aug; 31(8):918-21. PubMed ID: 2387518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.